BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
143 hedge funds and large institutions have $414M invested in BioDelivery Sciences International, Inc. in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 68 increasing their positions, 36 reducing their positions, and 24 closing their positions.
89% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 36
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
34% more call options, than puts
Call options by funds: $19.7M | Put options by funds: $14.6M
3% less funds holding
Funds holding: 147 → 143 (-4)
7% less capital invested
Capital invested by funds: $445M → $414M (-$30.9M)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$15.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.3M |
| 3 |
BC
Broadfin Capital
New York
|
+$11.2M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$6.3M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$36M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$11.6M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$8.46M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$8.04M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.02M |
BDSI Hedge Fund Activity: Q2 2015 in Review
143 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2015, worth a combined $414M — down 6.9% from $445M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of BDSI and 21 opened new positions — a net loss of 3 holders — while 36 trimmed existing stakes and 68 added.
The largest buyer was EverPoint Asset Management, adding an estimated $15.9M. The largest seller was Invesco, cutting an estimated $36M.
- 143 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2015, down from 147 in Q1 2015.
- Funds reported $414M of BioDelivery Sciences International, Inc. stock for Q2 2015, down 6.9% quarter-over-quarter.
- 21 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2015 and 24 closed out, a net change of -3 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2015 was EverPoint Asset Management, an estimated $15.9M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2015 was Invesco, an estimated $36M sold.
Based on aggregated 13F filings for Q2 2015.